Bordetella pertussis
The actual product may vary from the images shown on the website.
According to the WHO, respiratory tract infections are among the leading causes of morbidity and mortality in both infants and older age groups. Approximately 70% of these infections affect the upper respiratory tract and middle ear.
The diagnosis and treatment of respiratory infections remain a primary focus for both general practitioners and pediatricians, as they account for over 90% of all outpatient visits, particularly during autumn and winter.
Bordetella pertussis causes whooping cough (pertussis), an acute respiratory disease. It is clinically characterized by paroxysmal coughing spells and involvement of the respiratory, nervous, and cardiovascular systems, typically without primary intoxication or febrile reaction.
The gold standard for laboratory diagnosis of Bordetella pertussis is the culture of nasopharyngeal secretions during the first 2-3 weeks of illness; subsequently, the test's sensitivity declines. Serological testing (for antibodies to Bordetella pertussis antigens and toxin) is useful at later stages of infection. These tests have high specificity but relatively low sensitivity.
The Bordetella pertussis Real-Time PCR Detection Kit is in vitro DNA tests, which is intended for the specific identification of Bordetella pertussis in human biological samples.
The Bordetella pertussis Real-Time PCR Detection Kit is for research use only.
Certification: RUO
| Sample | Scrapes from posterior pharyngeal wall |
| NA extraction | PREP-NA, PREP-GS, PREP-RAPID |
| Storage requirements | +2...+8° С |
| Shelf life | 12 months |
|
Detection instruments |
Number of tests |
Tubes(ml)/ Strips |
Product number |
|
DT instruments (DNA-Technology), iCycler iQ (Bio-Rad) |
48 |
0.2 |
R1-P002-23/4EU |
|
0.2х8 |
R1-P002-S3/4EU |
